Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
683.00Today’s High
703.0052W low
448.6052W High
767.90Open Price
684.60Prev. Close
551.3500Volume
678791.00Value
466533054.30Fundamentals
Market Cap Cr
2219.30
Price to Earnings
39.00
Price to Book Value
2.70
Dividend Yield
0.40
PE to Growth
-4.60
Op Revenue TTM Cr
619.63
Net Profit TTM Cr
56.84
Cash From Operating Activity Cr
24.34
Return on Equity %
7.01
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
31.6
Week
47.2
Month
53.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
691.10
PIVOT
First Resistance
699.20
Second Resistance
711.10
Third Resistance
719.20
First Support
679.20
Second Support
671.10
Third Support
659.20
Relative Strength Index
68.62
Money Flow Index
79.82
MACD
15.55
MACD Signal
11.41
Average True Range
25.91
Average Directional Index
17.89
Rate of Change (21)
27.67
Rate of Change (125)
-2.54
Commodity Channel Index
174.5
Williams %R
-15.2
BETA
1 Month
1.01
3 Month
0.84
1 Year
0.56
3 Year
PRICE CHANGE ANALYSIS
↑ 9.62%
1 Week
Low
High
599.95
703
↑ 20.81%
1 Month
Low
High
528.05
703
↑ 8.34%
3 Months
Low
High
528.05
703
↓ -2.55%
6 Months
Low
High
528.05
740.15
↑ 17.42%
1 Year
Low
High
448.6
767.9
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 163.67 | 155.63 | 151.01 | 136.51 | 121.80 | 120.29 | 124.99 | 116.42 | 111.97 | 110.65 | 111.49 | |
| Operating Expenses Qtr | 116.06 | 113.39 | 114.31 | 100.10 | 90.76 | 81.96 | 86.58 | 80.54 | 77.63 | 75.42 | 76.33 | |
| Operating Profit Qtr | 43.27 | 38.16 | 32.55 | 32.18 | 25.10 | 33.78 | 34.14 | 31.23 | 30.21 | 30.89 | 31.94 | |
| EBIDT Qtr Cr | 47.61 | 42.24 | 36.70 | 36.41 | 31.03 | 38.33 | 38.41 | 35.88 | 34.34 | 35.23 | 35.17 | |
| Depreciation Qtr | 18.12 | 21.23 | 19.46 | 15.73 | 14.60 | 13.90 | 12.92 | 12.36 | 10.45 | 10.63 | 10.33 | |
| Net Profit Qtr | 18.42 | 13.59 | 11.31 | 15.25 | 11.81 | 16.86 | 17.97 | 16.80 | 19.33 | 17.23 | 12.54 | |
| Basic EPS Qtr | 5.70 | 4.28 | 3.60 | 4.86 | 3.76 | 5.37 | 5.73 | 5.35 | 5.85 | 5.97 | 4.51 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 606.82 | 483.49 | 469.82 | 661.48 | 193.18 | |
| Operating Expenses Annual Cr | 443.86 | 339.84 | 320.34 | 302.64 | 118.61 | |
| Operating Profit Annual | 146.16 | 124.25 | 134.55 | 93.81 | 64.28 | |
| Operating Profit Margin Annual % | 24.09 | 25.70 | 28.64 | 14.18 | 33.28 | |
| Total Expenses Annual Cr | 534.87 | 401.30 | 380.22 | 366.02 | 175.56 | |
| EBIDT Annual Cr | 162.96 | 143.66 | 149.48 | 358.83 | 74.57 | |
| EBIDT Annual margin % | 26.85 | 29.71 | 31.82 | 54.25 | 38.60 | |
| Depreciation | 74.55 | 53.78 | 41.39 | 37.44 | 32.33 | |
| PAT Before ExtraOrdinary Items Annual Cr | 58.56 | 63.51 | 70.70 | 184.93 | 12.47 | |
| Net Profit Annual | 58.56 | 63.51 | 70.70 | 184.93 | 12.47 | |
| Basic EPS Annual | 18.45 | 20.23 | 23.66 | 160.36 | 24.16 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 815.24 | 742.50 | 686.75 | -10.53 | 201.41 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 80.27 | 71.63 | 42.89 | 188.86 | 162.18 | |
| Total Current Liabilities Annual Cr | 276.05 | 95.25 | 147.41 | 183.81 | 181.29 | |
| Total Capital Plus Liabilities Annual Cr | 1171.57 | 909.38 | 877.05 | 604.53 | 544.88 | |
| Fixed Assets Annual | 657.00 | 496.15 | 413.95 | 312.23 | 284.23 | |
| Total Non Current Assets Annual | 749.16 | 682.79 | 541.29 | 356.39 | 327.11 | |
| Total Current Assets Annual | 422.41 | 226.59 | 335.77 | 248.14 | 217.77 | |
| Total Assets Annual | 1171.57 | 909.38 | 877.05 | 604.53 | 544.88 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 3.65 | 3.65 | 3.65 | 64.05 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 24.39 | 75.48 | 128.71 | 102.56 | 41.41 | |
| Cash from Investing Activity Annual | -128.88 | -108.54 | -241.10 | -61.14 | -79.31 | |
| Cash from Financing Annual Activity | 84.21 | -33.13 | 176.04 | 30.84 | 37.66 | |
| Net Cash Flow Annual | - | -66.19 | 63.65 | 72.26 | -0.24 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 252.47 | 236.48 | 218.72 | -16.20 | 117.09 | |
| ROE Annual % | 7.18 | 8.55 | 10.29 | -1757.04 | 20.63 | |
| ROCE Annual % | 9.87 | 11.03 | 14.81 | 76.39 | 11.61 | |
| Total Debt to Total Equity Annual | 0.20 | 0.02 | 0.04 | -19.26 | 3.84 | |
| EBDIT Annual Margin % | 27.61 | 30.95 | 32.85 | 90.50 | 40.77 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 170.62 | 162.40 | 159.61 | 143.80 | 139.15 | 122.64 | 127.21 | 117.50 | 112.35 | 110.81 | 111.49 | |
| Operating Expenses Qtr | 122.58 | 120.93 | 123.66 | 108.21 | 98.74 | 88.69 | 92.32 | 85.07 | 80.22 | 76.46 | 76.33 | |
| Operating Profit Qtr | 43.70 | 37.39 | 31.79 | 31.36 | 34.48 | 29.41 | 30.62 | 27.79 | 28.03 | 30.01 | 31.94 | |
| EBIDT Qtr Cr | 48.04 | 41.47 | 35.95 | 35.59 | 40.41 | 33.95 | 34.89 | 32.43 | 32.13 | 34.35 | 35.17 | |
| Depreciation Qtr | 18.12 | 21.23 | 19.46 | 15.73 | 14.60 | 13.90 | 12.92 | 12.36 | 10.45 | 10.63 | 10.33 | |
| Net Profit Qtr | 18.73 | 12.97 | 10.50 | 14.64 | 18.92 | 13.64 | 15.34 | 14.21 | 17.94 | 16.33 | 12.53 | |
| Basic EPS Qtr | 5.80 | 4.09 | 3.35 | 4.66 | 6.03 | 4.35 | 5.73 | 4.53 | 5.40 | 5.67 | 4.51 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Total Revenue Annual | 636.43 | 506.50 | 470.36 | |
| Operating Expenses Annual Cr | 475.39 | 364.82 | 323.97 | |
| Operating Profit Annual | 144.25 | 122.30 | 131.48 | |
| Operating Profit Margin Annual % | 22.66 | 24.15 | 27.95 | |
| Total Expenses Annual Cr | 566.42 | 426.30 | 383.85 | |
| EBIDT Annual Cr | 161.04 | 141.68 | 146.39 | |
| EBIDT Annual margin % | 25.30 | 27.97 | 31.12 | |
| Depreciation | 74.55 | 53.78 | 41.39 | |
| PAT Before ExtraOrdinary Items Annual Cr | 56.84 | 62.11 | 68.39 | |
| Net Profit Annual | 56.84 | 62.11 | 68.39 | |
| Basic EPS Annual | 17.31 | 19.29 | 22.88 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Total ShareHolders Funds Annual | 809.80 | 738.74 | 684.41 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 80.64 | 71.96 | 42.95 | |
| Total Current Liabilities Annual Cr | 281.47 | 99.19 | 148.80 | |
| Total Capital Plus Liabilities Annual Cr | 1171.91 | 909.89 | 876.15 | |
| Fixed Assets Annual | 657.00 | 496.15 | 413.95 | |
| Total Non Current Assets Annual | 750.73 | 684.13 | 542.01 | |
| Total Current Assets Annual | 421.19 | 225.76 | 334.15 | |
| Total Assets Annual | 1171.91 | 909.89 | 876.15 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 3.65 | 3.65 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Cash from Operating Activity Annual | 24.34 | 76.30 | 128.42 | |
| Cash from Investing Activity Annual | -128.88 | -108.89 | -240.64 | |
| Cash from Financing Annual Activity | 84.19 | -33.15 | 175.99 | |
| Net Cash Flow Annual | - | -65.73 | 63.78 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Book Value Per Share Annual | 250.79 | 235.28 | 217.98 | |
| ROE Annual % | 7.01 | 8.40 | 9.99 | |
| ROCE Annual % | 9.71 | 10.84 | 14.43 | |
| Total Debt to Total Equity Annual | 0.20 | 0.02 | 0.04 | |
| EBDIT Annual Margin % | 25.98 | 29.08 | 32.14 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ICICI PRUDENTIAL PHARMA HEALTHCARE AND DIAGANOSTIC | 2.73 | 74210100 | - | - |
| HDFC LIFE INSURANCE COMPANY LIMITED | 1.93 | 74210102 | - | - |
| ADITYA BIRLA SUN LIFE INSURANCE COMPANY LIMITED | 1.36 | 74210103 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| RAJENDRA KHIVRAJ MUTHA | 24.87 | 74210094 | 0 | 78.23 |
| KRSNA DIAGNOSTICS (MUMBAI) PRIVATE LIMITED | 2.16 | 74210096 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| TATA MUTUAL FUND - TATA SMALL CAP FUND | 7.4 | 74210099 |
| ICICI PRUDENTIAL PHARMA HEALTHCARE AND DIAGANOSTIC | 2.73 | 74210100 |
| K INDIA OPPORTUNITIES FUND LIMITED CLASS S | 2.19 | 74210106 |
| HDFC LIFE INSURANCE COMPANY LIMITED | 1.93 | 74210102 |
| ADITYA BIRLA SUN LIFE INSURANCE COMPANY LIMITED | 1.36 | 74210103 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| KIRANKUMAR PRABHAKAR BHISE | 1.52 | 74210116 |
| HUF | 0.84 | 74210109 |
| PHI CAPITAL TRUST - PHI CAPITAL GROWTH FUND - I | 15.44 | 74210112 |
| CYBAGE SOFTWARE PRIVATE LIMITED | 1 | 74210113 |
| KITARA PIIN 1104 | 1.26 | 74210119 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 15, 2023 | 2.75 | FINAL | - | Equity Share |
| Sep 15, 2022 | 2.5 | FINAL | Sep 16, 2022 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 18, 2024 | Audited Results & Final Dividend | - |
| Feb 12, 2024 | Quarterly Results | - |
| Nov 03, 2023 | Quarterly Results | - |
| Aug 12, 2023 | Quarterly Results | - |
| May 27, 2023 | Audited Results & Final Dividend | - |
| Feb 13, 2023 | Quarterly Results | - |
| Nov 09, 2022 | Quarterly Results | - |
| Aug 04, 2022 | Quarterly Results | - |
| May 28, 2022 | Audited Results & Final Dividend | - |
| Jan 31, 2022 | Quarterly Results | - |
| Oct 11, 2021 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
04 Jul 2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
Disclosure under Regulation 30 of SEBI (LODR), 2015- Awarding of the Tender for providing Tele-Reporting Services for Radiology.
03 Jul 2024
Krsnaa Diagnostics Ltd - 543328 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Confirmation Certificate in the matter of Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30, 2024.
01 Jul 2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled to be held on July 04, 2024.
01 Jul 2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled to be held on July 03, 2024.
27 Jun 2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled to be held on June 28, 2024.
24 Jun 2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled to be held on June 25, 2024.
22 Jun 2024
Krsnaa Diagnostics Ltd - 543328 - Closure of Trading Window
Intimation of closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 for quarter ending June 30, 2024.
13 Jun 2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled to be held on June 14, 2024.
10 Jun 2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled to be held on June 11, 2024.
06 Jun 2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled to be held on June 07, 2024.
